Physician profile
Eric S Hsu
NPI 1972537835
$4,267.00
in general payments reported to CMS, 2019-2025
25 companies · $883 in 2025
The $883 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $651 · 2020: $92.00 · 2021: $367 · 2022: $514 · 2023: $836 · 2024: $924 · 2025: $883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,643.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,734.33 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $761.56 | 2019-2025 | Eterna, Proclaim |
| Nalu Medical, INC. | $386.77 | 2023-2024 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $303.20 | 2019-2025 | Belbuca |
| Avanos Medical | $165.99 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $155.96 | 2024-2025 | |
| Tersera Therapeutics LLC | $94.70 | 2022-2025 | Prialt |
| Eagle Pharmaceuticals, INC. | $74.87 | 2023 | |
| Abbvie INC. | $63.92 | 2023-2025 | |
| Octapharma USA, INC. | $60.00 | 2021 | |
| Trevena, INC. | $51.90 | 2021 | |
| Averitas Pharma INC. | $45.62 | 2025 | Qutenza |
| Saluda Medical Americas, INC. | $45.57 | 2023-2025 | Evoke, Evoke Scs |
| Curonix LLC | $42.80 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pacira Pharmaceuticals Incorporated | $37.80 | 2024 | Exparel |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $37.28 | 2019 | |
| Spr Therapeutics, INC | $33.21 | 2022 | |
| Biotronik Nro, INC. | $32.69 | 2025 | Prospera |
| Painteq LLC | $31.66 | 2024 | Painteq |
| Allergan, INC. | $21.18 | 2019 | |
| Piramal Critical Care | $20.25 | 2019 | |
| Stimwave Technologies Incorporated | $18.66 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $17.63 | 2019 | |
| West Therapeutics Development, LLC | $15.74 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.